Who has invested in Affimed?

Aeris Capital, BioMedInvest, LSP Life Sciences Partners, Novo Nordisk A/S, Orbimed are named among the investors backing Affimed.

Affimed Funding: $25M Raised, Series D (2012)

Affimed funding overview

Affimed is based in Heidelberg, Germany. Affimed has raised $25M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in October 2012. The round record for Affimed runs through 2012; nothing later has been disclosed. Investors on record include Aeris Capital, BioMedInvest, LSP Life Sciences Partners, Novo Nordisk A/S, Orbimed. 5 distinct backers are named across the disclosed rounds.

Affimed at a glance

Total raised: $25M
Latest round: Series D
Latest round date: October 2012
Headquarters: Heidelberg, Germany
Notable investors: Aeris Capital, BioMedInvest, LSP Life Sciences Partners, Novo Nordisk A/S, Orbimed

Frequently asked about Affimed funding

How much has Affimed raised?: Affimed has raised $25M in total disclosed funding across the rounds on record.
Who has invested in Affimed?: Aeris Capital, BioMedInvest, LSP Life Sciences Partners, Novo Nordisk A/S, Orbimed are named among the investors backing Affimed.
What was the latest Affimed funding round?: The most recent disclosed round is a Series D, announced in October 2012.
Where is Affimed based?: Affimed is based in Heidelberg, Germany.
When did Affimed last raise?: The last disclosed Affimed round closed in October 2012 at Series D.

Round data for Affimed is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Heidelberg and backer lists below.

Affimed Funding: $25M Raised, Series D (2012)

Affimed funding overview

Affimed at a glance

Frequently asked about Affimed funding

Companies related to Affimed (33)

Browse related funding lists (3)